TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | -3 | -4 | -14 | 0 | 0 | -7 |
| P | %wins | 100 | 0 | 0 | 0 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/27/22 17:31 | 12/22/22 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Glenn Jeffrey S | CA | D | P | 128 | 1.28 | 0 | 100 | 42 | 339 | D | ||||||||||||||||
8/12/20 18:28 | 8/11/20 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Glenn Jeffrey S | CA | D | P.m | 115 | 11.46 | 0 | 10 | 5 | 228 | M | ||||||||||||||||
3/17/20 17:16 | 3/16/20 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Glenn Jeffrey S | CA | D | P | 151 | 5.03 | 0 | 30 | 16 | 218 | D | ||||||||||||||||
9/5/17 18:20 | 9/1/17 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Glenn Jeffrey S | CA | D | P | 143 | 9.53 | 0 | 15 | 9 | 183 | D | ||||||||||||||||
11/21/16 17:11 | 11/17/16 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Glenn Jeffrey S | CA | D | P.m | 197 | 12.74 | 0 | 15 | 10 | 168 | M | -92 | -23 | -34 | -20 | 2 | 16 | 12 | 9 | 0 | -3 | -4 | -14 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |